Alembic Group Stocks

1 Yr CAGR -11.42%

3 Yr CAGR -0.06%

Total Companies 3

List of Alembic Stocks as on 20-Sep-2026

Filter

	Company Name	DeciZen	CMP	Price Change	Market Cap (Cr)	52 Week High	52 Week Low	ROE	P/E Ratio	P / BV	EV/ EBITDA
1	Alembic Pharma	4 Q V+ PT	846	2.35%	16,623 Small Cap	998 04 Nov, 25	635 23 Mar, 26	12.64	23.97	2.84	14.44	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
2	Alembic	4 Q V+ PT	103	-0.17%	2,637 Small Cap	118 03 Sep, 26	70.64 30 Mar, 26	13.14	8.23	1.07	16.36	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
3	Paushak	4 Q V PT	718	-1.09%	1,770 Small Cap	991 03 Oct, 25	343 30 Mar, 26	0.00	-	0.00	-	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History

Top Business Houses

Tata

26 Companies

Market Cap: ₹ 25,28,346 Cr.

1 Yr CAGR -8.56%

3 Yr CAGR 2.22%

Mukesh Ambani

8 Companies

Market Cap: ₹ 18,36,610 Cr.

1 Yr CAGR -19.25%

3 Yr CAGR -3.83%

Adani

7 Companies

Market Cap: ₹ 17,10,382 Cr.

1 Yr CAGR 26.25%

3 Yr CAGR 11.11%

Bajaj

12 Companies

Market Cap: ₹ 14,83,666 Cr.

1 Yr CAGR -8.46%

3 Yr CAGR 18.53%

HDFC

4 Companies

Market Cap: ₹ 14,05,903 Cr.

1 Yr CAGR -12.89%

3 Yr CAGR 3.84%

Bharti

3 Companies

Market Cap: ₹ 13,43,037 Cr.

1 Yr CAGR -6.00%

3 Yr CAGR 25.49%

PSU - SBI

4 Companies

Market Cap: ₹ 12,66,360 Cr.

1 Yr CAGR -5.43%

3 Yr CAGR 5.13%

ICICI

4 Companies

Market Cap: ₹ 12,64,311 Cr.

1 Yr CAGR 0.92%

3 Yr CAGR 6.18%

News about Alembic Stocks in India

Sep, 2026

Alembic Pharmaceuticals informs about disclosure

Alembic Pharmaceuticals has informed that the company has successfully completed an unannounced onsite Bioequivalence inspection conducted by United States Food and Drug Administration (‘USFDA’) at the Company’s Bioequivalence Facility located in Vadodara, Gujarat, with no Form 483 observations. The unannounced onsite USFDA Bioequivalence inspection was conducted from 31st August, 2026 to 10th September, 2026.

The above information is a part of company’s filings submitted to BSE.

Sep, 2026

USFDA completes inspection at Alembic Pharmaceuticals’ Bioequivalence Facility in Vadodara

The inspection was conducted at the company’s Bioequivalence Facility located in Vadodara and concluded with no Form 483 observations

Sep, 2026

Alembic Pharmaceuticals incorporates subsidiary in Dubai

The new entity has been incorporated to explore new business opportunities and to promote, sale and distribute pharmaceutical product(s) of the company

Aug, 2026

Alembic informs about newspaper cuttings

Alembic has informed that it enclosed newspaper cuttings related to advertisement published for Unaudited Financial Results of the Company for the Quarter ended on 30th June, 2026, in Indian Express (English Edition) and Financial Express (Gujarati Edition- vernacular language) on 12th August, 2026. The said newspaper advertisement provides a Quick Response (QR) Code and the weblink of the Company's website to access complete financial results for the said period. The said newspaper cuttings are also available on the website of the Company at Investors Section.

The above information is a part of company’s filings submitted to BSE.

Aug, 2026

Alembic - Quaterly Results

A slight decline in the revenue of Rs. 462.70 millions was seen for the June 2026 quarter as against Rs. 478.90 millions during year-ago period.The Net Profit of the company registered a slight decline of -14.25% to Rs. 146.80 millions from Rs. 171.20 millions.The Operating Profit of the company witnessed a decrease to 195.90 millions from 220.30 millions.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202606	202506	% Var	202606	202506	% Var	202603	202503	% Var
Sales	462.70	478.90	-3.38	462.70	478.90	-3.38	2319.30	2143.60	8.20
Other Income	55.50	34.50	60.87	55.50	34.50	60.87	727.70	745.10	-2.34
PBIDT	195.90	220.30	-11.08	195.90	220.30	-11.08	1604.70	1640.70	-2.19
Interest	3.70	4.20	-11.90	3.70	4.20	-11.90	15.70	18.30	-14.21
PBDT	192.20	216.10	-11.06	192.20	216.10	-11.06	1589.00	1622.40	-2.06
Depreciation	33.80	27.00	25.19	33.80	27.00	25.19	120.10	102.40	17.29
PBT	158.40	189.10	-16.23	158.40	189.10	-16.23	1468.90	1520.00	-3.36
TAX	11.60	17.90	-35.20	11.60	17.90	-35.20	223.50	100.50	122.39
Deferred Tax	-4.30	0.00	0.00	-4.30	0.00	0.00	0.50	-51.40	-100.97
PAT	146.80	171.20	-14.25	146.80	171.20	-14.25	1245.40	1419.50	-12.26
Equity	513.56	513.56	0.00	513.56	513.56	0.00	513.56	513.56	0.00
PBIDTM(%)	42.34	46.00	-7.96	42.34	46.00	-7.96	69.19	76.54	-9.60

Aug, 2026

Alembic Pharmaceuticals shines on reporting 12% rise in Q1 consolidated net profit

Consolidated total income of the company increased by 26.06% to Rs 2,164.70 crore in Q1FY27

Track Now:

5 Star Companies Large Cap Companies Mid Cap Companies Small Cap Companies Nifty Microcap Companies Top IT Companies Tax saver funds Analyze your Equity Funds Nifty Index Funds

You have 96 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Alembic Group Stocks

Top Business Houses

Tata

Mukesh Ambani

Adani

Bajaj

HDFC

Bharti

PSU - SBI

ICICI

News about Alembic Stocks in India

Alembic Pharmaceuticals informs about disclosure

USFDA completes inspection at Alembic Pharmaceuticals’ Bioequivalence Facility in Vadodara

Alembic Pharmaceuticals incorporates subsidiary in Dubai

Alembic informs about newspaper cuttings

Alembic - Quaterly Results

Alembic Pharmaceuticals shines on reporting 12% rise in Q1 consolidated net profit

Track Now:

Trending Blogs